Navigation Links
Cardium Regains Listing Compliance With NYSE Amex
Date:1/6/2012

SAN DIEGO, Jan. 6, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported that it had received notice from NYSE Regulation that the Company is now considered to have regained compliance with the listing requirements of the NYSE Amex LLC (formerly the American Stock Exchange).

(Logo:  http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

In the communication from its listing exchange, Cardium was informed that based upon a review of information provided by the Company and publicly available information, including the Company's Form 8-K filed on January 3, 2012, the Company has resolved the continued listing deficiencies referenced in the NYSE Amex LLC's letter dated November 26, 2010, as previously reported.  In addition, the Exchange also indicated that as with the case for all listed issuers, the Company's continued listing eligibility will continue to be assessed on an ongoing basis and that the Company is subject to the provisions of Section 1009(h) of the NYSE Amex Company Guide, which may be accessed at www.nyse.com/regulation.

About Cardium

Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering and other economic monetizations.  Cardium's current medical opportunities portfolio, which is focused on health sciences and regenerative medicine, includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium Health Sciences healthy lifestyle product platform.  The Company's lead commercial product Excellagen™ topical gel for wound care management, has
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
7. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
8. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
11. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/17/2013)... May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will release ... 31, 2013, before market on Tuesday, May 28, 2013.  The ... 2013, at 8:00 a.m. EDT (May 28, 2013 at 8:00 ... and provide an update on recent corporate developments. ...
(Date:5/16/2013)... May 17, 2013 Singapore,s ... Switzerland,s Cytos Biotechnology AG today announced ... Phase 1 clinical trial with their H1N1 influenza vaccine candidate ... In this first Phase 1 clinical trial, the safety and ... protect against H1N1 influenza infection will be evaluated. ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... Four-time NASCAR Cup Series champion Jeff Gordon, known ... he is for his philanthropic activities and tireless support ... the Alabama tornado relief effort through the Jeff Gordon ... clothing for babies and children affected by the destruction. ...
... Genomic Health, Inc. (Nasdaq: GHDX ) ... the American Society of Clinical Oncology (ASCO) Annual Meeting, ... of the Onco type DX® colon cancer Recurrence ... in stage II colon cancer.  The company also will ...
Cached Medicine Technology:Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 2Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 3Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 4Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 5Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 2Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 3Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 4Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 5Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 6Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 7Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 8Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 9
(Date:5/19/2013)... At a May 6th, 2013 meeting ... Physicians (NCAPIP), the Pacific Chronic Disease Coalition (PCDC), ... Disease Directors (NACDD), presented a newly published assessment ... non-communicable diseases (NCDs) in the U.S. Associated Pacific ... Hawaii Journal of Medicine and Public Health, highlights ...
(Date:5/19/2013)... ─ Gourmands and foodies everywhere have long recognized ginger ... zing to both sweet and savory dishes; now, a ... of the spicy root also may have properties that ... of the study will be presented at the ATS ... a tightening of the bronchial tubes that carry air ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 People in Minnesota ... summer. Altman Fitness is offering its 28 Day Fat Loss ... program from the comfort of their own home. The product ... purchase. More information can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ ... to leave their houses now, but after using the 28 ...
(Date:5/19/2013)... Today, Zane Benefits, Inc. published ... insurance . Zane Benefits, which provides comprehensive and ... is the leader in health care reform, ... . , According to Zane Benefits’ website, many ... the value of small business health insurance for ...
(Date:5/19/2013)... TX (PRWEB) May 19, 2013 ... analysis for US, UK, Spain, Japan, Italy, Germany ... to the molecular diagnostics laboratory practice, as well ... trends with significant market impact during the next ... DNA probe and biochip technologies, test formats, detection ...
Breaking Medicine News(10 mins):Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 2Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 3Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4
... Health Corp. (Nasdaq:,WBMD) today announced the honorees of the ... of WebMD the Magazine. The third,annual WebMD Health Heroes ... vision and drive to inspire others to action., ... Cancer, Laura Ziskin, breast cancer survivor and Hollywood ...
... Trane CleanEffects(TM) May Lower Risk of, Serious Health Outcomes ... ... Inside the Home, TYLER, Texas, Nov. 11 A new ... Inc. (EH&E),in collaboration with professors at the Harvard School of Public ...
... of 2008 May Offer Little Hope for Many ... 10:30am-11:30am,card-carrying veterans visiting St. Anthony Foundation will receive ... and tea. While many,may be categorically eligible for ... through Veterans, Bond Act of 2008 (S.B. 1572, ...
... features sneak peek and tips from YOU Docs, latest ... doctors Mehmet,Oz, MD, and Michael Roizen, MD, first challenged ... York Times #1 best-seller in 2005. Now,these same physicians ... book series -- want to know, "What stands in ...
... an Important Employee Benefit for Health-Conscious ... ... BioIQ,( http://www.bioiq.com ), a leading supplier of health screening and ... and supply chain software, is offering BioIQ,s home test,kits to its ...
... Caring.com, baby boomers caring for an aging parent are playing an active ... ... San Mateo, Calif. (PRWEB) November 11, 2008 -- According to a new ... an active role when it comes to decisions about their parents, medications. ...
Cached Medicine News:Health News:WebMD Announces 2008 Health Heroes 2Health News:WebMD Announces 2008 Health Heroes 3Health News:Whole-House Air Cleaner May Help Prevent Asthma Attack, Heart Attack and Stroke 2Health News:Whole-House Air Cleaner May Help Prevent Asthma Attack, Heart Attack and Stroke 3Health News:Homeless Veterans Turn to St. Anthony's Dining Room for Help on Veterans Day 2Health News:Doctors Reveal Biology of Beauty in New Book 2Health News:Software Vendor QAD Rolls Out BioIQ Health Testing Program to National Workforce 2Health News:Boomers Play an Active Role with Parent's Medication Decisions 2
... fully automated high-throughput glass-on-glass coverslipper. The ... microscope glass slides bearing tissue sections ... quality-grade coverslips of different standard sizes ... capability of handling a large variety ...
... mountant media dispensing system eliminates ... under the coverglass. All new ... most automated staining machines. Available ... pre-filled coverglass and mountant dispensers. ...
... Trellis Infusion Catheter enables the physician to ... fluid, and disperse the agent by means ... Trellis is a multi-lumen catheter with two ... and infusion holes located between these balloons. ...
ACRYSOF®, Posterior Chamber Intraocular Lenses are indicated for the replacement of the human lens to achieve visual correction of aphakia in patients sixty years and older. These lenses are i...
Medicine Products: